Literature DB >> 22221950

Coronary artery disease in patients with psoriasis referred for coronary angiography.

April W Armstrong1, Caitlin T Harskamp, Lynda Ledo, Jason H Rogers, Ehrin J Armstrong.   

Abstract

Patients with psoriasis may have an increased risk of cardiovascular disease and myocardial infarction. The aim of this study was to investigate whether psoriasis is associated with an increased prevalence of coronary artery disease (CAD) independent of established cardiovascular risk factors in patients undergoing coronary angiography. A retrospective cohort analysis was performed by linking records of all patients undergoing coronary angiography from 2004 through 2009 with dermatology medical records. From an overall cohort of 9,473 patients, we identified 204 patients (2.2%) with psoriasis before coronary angiography. Patients with psoriasis had higher body mass index (31.3 ± 8.1 vs 29.3 ± 7.1 kg/m(2), p <0.001) but the prevalence of other risk factors was similar. Median duration of psoriasis before cardiac catheterization was 8 years (interquartile range 2 to 24). Patients with psoriasis were more likely to have CAD (84.3% vs 75.7%, p = 0.005) at coronary angiography. After adjusting for established cardiovascular risk factors, psoriasis was independently associated with presence of angiographically confirmed CAD (adjusted odds ratio 1.8, 95% confidence interval 1.2 to 2.8, p = 0.006). In patients with psoriasis, duration of psoriasis >8 years was also independently associated with angiographically confirmed CAD after adjusting for established cardiovascular risk factors (adjusted odds ratio 3.5, 95% confidence interval 1.3 to 9.6, p = 0.02). In conclusion, patients with psoriasis and especially those with psoriasis for >8 years have a higher prevalence of CAD than patients without psoriasis undergoing coronary angiography. Copyright Â
© 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22221950     DOI: 10.1016/j.amjcard.2011.11.025

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  26 in total

Review 1.  Diet and dermatology: the role of dietary intervention in skin disease.

Authors:  Rajani Katta; Samir P Desai
Journal:  J Clin Aesthet Dermatol       Date:  2014-07

2.  The relationship between duration of psoriasis, vascular inflammation, and cardiovascular events.

Authors:  Alexander Egeberg; Lone Skov; Aditya A Joshi; Lotus Mallbris; Gunnar H Gislason; Jashin J Wu; Justin Rodante; Joseph B Lerman; Mark A Ahlman; Joel M Gelfand; Nehal N Mehta
Journal:  J Am Acad Dermatol       Date:  2017-08-18       Impact factor: 11.527

Review 3.  Unmet Needs in the Pathogenesis and Treatment of Cardiovascular Comorbidities in Chronic Inflammatory Diseases.

Authors:  Cristina Panico; Gianluigi Condorelli
Journal:  Clin Rev Allergy Immunol       Date:  2018-12       Impact factor: 8.667

Review 4.  IL-17 in psoriasis: implications for therapy and cardiovascular co-morbidities.

Authors:  Jackelyn B Golden; Thomas S McCormick; Nicole L Ward
Journal:  Cytokine       Date:  2013-04-04       Impact factor: 3.861

Review 5.  Updates on cardiovascular comorbidities associated with psoriatic diseases: epidemiology and mechanisms.

Authors:  Kaitlyn M Yim; April W Armstrong
Journal:  Rheumatol Int       Date:  2016-05-24       Impact factor: 2.631

6.  Abnormal lipoprotein particles and cholesterol efflux capacity in patients with psoriasis.

Authors:  Nehal N Mehta; Ron Li; Parasuram Krishnamoorthy; YiDing Yu; William Farver; Amrith Rodrigues; Anna Raper; Mackenzie Wilcox; Amanda Baer; Stephanie DerOhannesian; Megan Wolfe; Muredach P Reilly; Daniel J Rader; Abby VanVoorhees; Joel M Gelfand
Journal:  Atherosclerosis       Date:  2012-07-21       Impact factor: 5.162

Review 7.  Psoriasis and comorbid diseases: Epidemiology.

Authors:  Junko Takeshita; Sungat Grewal; Sinéad M Langan; Nehal N Mehta; Alexis Ogdie; Abby S Van Voorhees; Joel M Gelfand
Journal:  J Am Acad Dermatol       Date:  2017-03       Impact factor: 11.527

Review 8.  Psoriasis and major adverse cardiovascular events: a systematic review and meta-analysis of observational studies.

Authors:  Ehrin J Armstrong; Caitlin T Harskamp; April W Armstrong
Journal:  J Am Heart Assoc       Date:  2013-04-04       Impact factor: 5.501

Review 9.  microRNAs involved in psoriasis and cardiovascular diseases.

Authors:  Sara Sileno; Sara Beji; Marco D'Agostino; Alessandra Carassiti; Guido Melillo; Alessandra Magenta
Journal:  Vasc Biol       Date:  2021-06-03

10.  Psoriasis and Cardiovascular Risk: Strength in Numbers Part 3.

Authors:  Alexis Ogdie; Andrea B Troxel; Nehal N Mehta; Joel M Gelfand
Journal:  J Invest Dermatol       Date:  2015-09       Impact factor: 8.551

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.